Ireland

UK vector
#Brexit #Clinical trials #Drug discovery #Ireland #UK

Biogen’s vision for UK & Ireland  

DDW Editor Reece Armstrong speaks to Kylie Bromley, General Manager and Managing Director of Biogen UK & Ireland, about her career within the life sciences industry and the challenges of navigating a large pharma company within the UK and Ireland.   RA: Could you tell us about your career… Read More

#Exclusive Content

#Cystic fibrosis #Ireland #Paediatrics #Respiratory #Vertex

Landmark study supports use of cystic fibrosis drug in newborns

A cystic fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research has found. The study, involving RCSI University of Medicine and Health Sciences and Children’s Health Ireland, included… Read More

#News